With the identification and definition of the two novel genetic subtypes involving PAX5 and identifying PAX5 as one of the key players also in Ph-like ALL [7,11,12], there is a growing interest in investigating the various changes and underlying mechanisms, as well as their implications for patient prognoses. This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.